CA
Can-Fite BioPharma Ltd.
CANF · AMEX
$2.25 +4.17% (+$0.09)
1M -37.21%
Market Cap $2.85M
P/E Ratio -
Div. Yield -
ROE 201.06%
Piotroski F-Score Weak
2/9Valuation
58 /100
Fair P/B 0.51x
P/S 7.05x
P/FFO N/A
Growth
15 /100
Declining Book val. growth 7.73%
Rev. growth 20.42%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 2,456.79%
Gross margin 100.00%
FCF margin 2,210.12%
Quality
1 /100
Poor ROA 103.30%
ROIC 145.49%
Asset turnover 0.04x
Debt
100 /100
Low Current ratio 3.46x
Debt/Equity 0.01x
Debt/Assets N/A
Stability
20 /100
Unstable EPS volatility 611.96%
Beta 0.02x
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre CANF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Motti Farbstein
Employees
5
Headquarters
Ramat Gan
Evenimente viitoare
01 APR.
Earnings
Upcoming earnings report